Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

American Oriental Signs Up with US CRO for Clinical Trials

publication date: Feb 15, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
American Oriental Bioengineering has struck a deal with Palm Beach Clinical Research Organization (PBCRO) of the US to use PBCRO to oversee American clinical trials of AOBO-developed pharmaceuticals. American Oriental did not disclose which of its products it plans to enter into the process of FDA registration. AOBO, which is headquartered in the Beijing E-Town Economic and Technology Development Area, makes both prescription and OTC products. More details....

Stock Symbol: (NYSE: AOB)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors